Emtricitabine, rilpivirine, and tenofovir and Ibritumomab
Determining the interaction of Emtricitabine, rilpivirine, and tenofovir and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine, rilpivirine, and tenofovir-Ibritumomab Intravenous
- Emtricitabine, rilpivirine, and tenofovir-Ibritumomab Tiuxetan
- Emtricitabine, rilpivirine, and tenofovir-Ibrutinib
- Emtricitabine, rilpivirine, and tenofovir-Ibrutinib Capsules
- Emtricitabine, rilpivirine, and tenofovir-Ibrutinib Tablets
- Emtricitabine, rilpivirine, and tenofovir-Ibu
- Ibritumomab-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Ibritumomab-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Ibritumomab-Emtriva
- Ibritumomab-Emtriva (Emtricitabine Capsules)
- Ibritumomab-Emtriva (Emtricitabine Solution)
- Ibritumomab-Emverm